Skip to main content
Pharmagreen Biotech Inc. (PHBI)
OTCMKTS · Delayed Price · Currency is USD
0.0017
-0.0001 (6.25%)
Mar 9, 2026, 11:43 AM EST

Pharmagreen Biotech Cash Flow Statement

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
 Dec '24 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 2019 - 2017
Net Income
-0.23-1-0.57-0.88-4.53-2.44
Upgrade
Other Amortization
--0.070.020.090.33
Upgrade
Asset Writedown & Restructuring Costs
-----0.43
Upgrade
Stock-Based Compensation
--0.080.460.630.01
Upgrade
Other Operating Activities
-0.070.720-0.273.71.19
Upgrade
Change in Accounts Receivable
00-0-000.01
Upgrade
Change in Inventory
00-0.01---
Upgrade
Change in Accounts Payable
0.150.130.140.070.15-0.09
Upgrade
Change in Other Net Operating Assets
0.110.120.220.18-0.24-0.06
Upgrade
Operating Cash Flow
-0.03-0.03-0.07-0.43-0.21-0.61
Upgrade
Short-Term Debt Issued
----0.030.1
Upgrade
Long-Term Debt Issued
-0.030.080.14-0.6
Upgrade
Total Debt Issued
0.040.030.080.140.030.7
Upgrade
Short-Term Debt Repaid
-----0.04-0.14
Upgrade
Long-Term Debt Repaid
--0--0.01--0.03
Upgrade
Total Debt Repaid
-0-0--0.01-0.04-0.17
Upgrade
Net Debt Issued (Repaid)
0.040.030.080.13-0.010.53
Upgrade
Issuance of Common Stock
---0.190.270.04
Upgrade
Other Financing Activities
------0.01
Upgrade
Financing Cash Flow
0.040.030.080.310.260.56
Upgrade
Foreign Exchange Rate Adjustments
-0.01-0-0.020.1-0.04-0.01
Upgrade
Net Cash Flow
0-0-0.01-0.020.01-0.05
Upgrade
Free Cash Flow
-0.03-0.03-0.07-0.43-0.21-0.61
Upgrade
Free Cash Flow Margin
-1098.63%-823.64%-2462.91%---
Upgrade
Free Cash Flow Per Share
----0.00-0.00-0.01
Upgrade
Cash Interest Paid
-----0
Upgrade
Levered Free Cash Flow
-0.160.790.18-0.17-1.020.59
Upgrade
Unlevered Free Cash Flow
-0.140.810.19-0.16-0.630.68
Upgrade
Change in Working Capital
0.260.250.350.24-0.09-0.13
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.